Opioid ligands are a class of G protein-coupled receptors known as opioid receptors. Dynorphins, enkephalins, endorphins, endomorphins, and nociceptin are examples of endogenous opioids. There are many opioid receptors in the brain, as well as in the spinal cord and digestive system. The body has molecules or sites called opioid receptors that are triggered by opioid substances. Opioid receptors prevent impulses from traveling along excitatory pathways in the human body.The serotonin, catecholamine, and substance P pathways are some of these pathways, and they are all thought to play a role in pain perception and feelings of wellbeing. Mu, delta, and kappa receptors are additional subclassifications of opioid receptors. While each class has its own unique way of acting, they all have some fundamental things in common. The potassium pump mechanism, which is present on the plasma membrane of most cells, powers them all.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V69961 | Bilaid C | 2393866-13-0 | Bilaid C is a tetrapeptide extracted from the Australian estuarine Penicillium strain MST-MF667. |
|
V109928 | Biphalin acetate | Dienorphin (acetate) is an opioid peptide analog that can cross the brain barrier and contains two active enkephalin pharmacophores. | |
|
V69960 | Biphalin TFA | 126872-95-5 | Biphalin TFA is a brain barrier-penetrating opioid peptide analog containing two active enkephalin pharmacophores. |
|
V103236 | Bipiperidinyl 4-ANPP | 2515737-24-1 | Bispiperidinyl 4-ANPP is a structural analog of opioid compounds. |
|
V69894 | BMS-986121 | 313671-26-0 | BMS-986121 is a PAM (positive allosteric modulator) of μ opioid receptor found in patent WO2014107344. |
|
V130424 | BNTX | 129468-28-6 | BNTX is a highly selective δ1 opioid receptor antagonist. |
|
V130425 | BNTX maleate | 864461-31-4 | BNTX maleate is a δ1-opioid receptor antagonist with Ki values of 0.1, 10.8, 13.3, and 58.6 nM for δ1, δ2, μ, and κ opioid receptors, respectively. |
|
V69887 | BPR1M97 | 2059904-66-2 | BPR1M97 is a dual-acting (bifunctional) agonist at mu opioid receptor (MOP) and nociceptin-orphanin FQ peptide (NOP) receptors with Ki of 1.8 and 4.2 nM, respectively. |
|
V103692 | BPRMU191 | 2131199-52-3 | BPRMU191 is a μ-opioid receptor (MOR) modulator that exerts analgesic effects by converting a small molecule morphine antagonist into a G protein-biased MOR agonist to induce MOR activation. |
|
V50977 | BRL-52537 HCl | 112282-24-3 | BRL 52537 HCl is a selective kappa-opioid receptor (KOR) agonist/activator with Ki of 0.24 nM and 1560 nM for the kappa and mu subtypes, respectively. |
|
V115408 | BRL-52656 | 115642-84-7 | BRL-52656 is a κ opioid receptor agonist that can cross the blood-brain barrier (BBB) and exhibits biphasic effects. |
|
V102744 | Bromadol | 77239-98-6 | Bromadol is an opioid compound. |
|
V102782 | Bromadoline | 67579-24-2 | Bromodorin is an opioid compound that exhibits antinociceptive activity in rodents. |
|
V93723 | BTF | BTF has selective binding affinity for OX1R, with Ki values of 2.33 nM and 62.8 nM for OX1R and OX2R, respectively. | |
|
V130733 | BU72 | 173265-76-4 | BU72 is a potent and long-acting μ and κ opioid receptor agonist, and also has partial agonistic activity against δ opioid receptors (EC50 values of 0.054, 0.033 and 0.58 nM, respectively). |
|
V69883 | BW-180C ([D-Ala2, D-Leu5]-Enkephalin; DADLE) | 63631-40-3 | BW-180C ([D-Ala2, D-Leu5]-Enkephalin) is a water-soluble (H2O-soluble) peptide opioid receptor (Opioid Receptor) agonist. |
|
V130921 | CA1001 | CA1001 is a small molecule ZNF74 inhibitor and a peripherally restricted κ/δ dual opioid receptor agonist. | |
|
V69888 | CCG258747 | 2615910-00-2 | CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity for GRK1, GRK5, PKA and ROCK1 (518, 83, >5500 and >550-fold, respectively). |
|
V112696 | CCI-1008 | 224785-54-0 | CCI-1008 is an opioid receptor agonist. |
|
V131559 | Chlorphine | 6440-26-2 | Chlorphine is a neuroactive halogenated opioid analog. |